IC<sub>50</sub> of RTKIs for NSCLC cell lines with and without T790M mutation.

NIAID Data Ecosystem2026-03-08 收录

数据链接：

https://figshare.com/articles/dataset/_IC_50_of_RTKIs_for_NSCLC_cell_lines_with_and_without_T790M_mutation_/1518323 数据链接链接失效反馈

官方服务：

资源简介：

IC50 of RTKIs for NSCLC cell lines with and without T790M mutation.

创建时间：

2015-08-24

MOESM5 of Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers

肿瘤药敏测试

癌症精准医疗

Additional file 5: Table S4. Tumor type-specific drug associations identified using 37-drug library. Wilcoxon rank sum test was applied to determine the relative differences of drug sensitivity betwee

Figshare2024-02-15 更新50

Differences and significance at lowest tested concentration (LTC) and clinically achievable concentration (CAC) in numbers of logs of cell kill between p53 non-functional vs. functional cell lines, between p16/14 null vs. wild lines, and between lines established at diagnosis vs. those established at PD or post-chemo.

肿瘤药敏测试

癌症细胞系功能分析

NIAID Data Ecosystem30

Additional file 2: of Intertumoral heterogeneity in patient-specific drug sensitivities in treatment-naïve glioblastoma

肿瘤药敏测试

胶质母细胞瘤治疗

Drug collection. The drug collection used in this study (XLSX 73 kb)

Figshare2019-06-25 更新20

16 prostatic cancer cell lines and sensitivity to an anticancer tumor agent dasatinib

肿瘤药敏测试

癌症生物标志物

Transcriptional profiling was conducted on RNA from 16 prostatic cancer cell lines to identify genes whose expression level correlate with sensitivity of an anti-tumor agent (dasatinib). Keywords: com

NIAID Data Ecosystem40

IC50 values for medulloblastoma and glioblastoma cell lines.

肿瘤药敏测试

药物筛选评估

The half-maximal inhibitory concentrations (IC50) calculated for LLL12 and other STAT3/JAK2 inhibitors (µM) in medulloblastoma and glioblastoma cell lines. Cellular proliferation was measured using a

Figshare2015-12-02 更新30

IC<sub>50</sub> of RTKIs for NSCLC cell lines with and without T790M mutation.

资源简介：

相关数据集